Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
162M
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
177M
-
Shares change
-
+3.58M
-
Total reported value, excl. options
-
$2.35B
-
Value change
-
+$49.3M
-
Put/Call ratio
-
0.18
-
Number of buys
-
93
-
Number of sells
-
-76
-
Price
-
$13.31
Significant Holders of IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) as of Q4 2019
211 filings reported holding IRWD - IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK as of Q4 2019.
IRONWOOD PHARMACEUTICALS INC - COMMON-STOCK (IRWD) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 177M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (21.7M shares), BROWN CAPITAL MANAGEMENT LLC (17.9M shares), VANGUARD GROUP INC (16.6M shares), BlackRock Inc. (13.5M shares), FMR LLC (10.8M shares), Sarissa Capital Management LP (10.3M shares), UBS ASSET MANAGEMENT AMERICAS INC (8.74M shares), JANUS HENDERSON GROUP PLC (8.29M shares), MFN Partners Management, LP (6.44M shares), and STATE STREET CORP (5.77M shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.